Intraoperative dynamic MRI: Localization of sites of brain tumor recurrence after highdose radiotherapy

Journal of Magnetic Resonance Imaging

Volumn 8, Issue 5, 1998, Pages 1085-1089

  Schwartz, Richard B ^a   Hsu, Liangge ^a   Kacher, Daniel F ^a   Wong, Terence Z ^a   Alexander III, Eben ^a   Okon, Stephen ^a   Guttmann, Charles R G ^a   Black, Peter McL ^a   Kelley, Raymond A ^a   Moriarty, Thomas ^a   Martin, Claudia ^a   Isbister, Holly G ^a   Cahill, Cheryl D ^a   Spaulding, Sharon A ^a   Jolesz, Ferenc A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Astrocytomas; Brain metastases; Brain neoplasms; Contrast agents; MRI, interventional

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; BRAIN TUMOR; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOSURGERY; TUMOR LOCALIZATION; TUMOR RECURRENCE;

BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; INTRAOPERATIVE CARE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RADIOTHERAPY, HIGH-ENERGY; SENSITIVITY AND SPECIFICITY;

EID: 0031757930     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880080513     Document Type: Article

References (16)

1. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986; 158:149-155.
2. Schwartz RB, Carvalho PA, Alexander E III, Loeffler JS, Folkerth R, Holman BL. Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with T1-201 and Tc99m-HMPAO. AJNR Am J Neuroradiol 1991; 12:1187-1192.
3. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 1996; 6:743-752.
4. Schenck JF, Jolesz FA, Roemer PB, et al. Superconducting open-configuration MR imaging system for image-guided therapy. Radiology 1995; 195:805-814.
5. Silverman SG, Collick BD, Figueira MR, et al. Interactive MR-guided biopsy in an open-configuration MR imaging system. Radiology 1995; 197:175-181.
6. Leibel SA, Scott CB, Loeffler JS. Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol 1994; 21:198-219.
7. Wen PY, Alexander E III, Black PM, et al. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 1994; 73:3029-3036.
8. Burger PC, Dubois PJ, Schold SC, et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 1983; 58:159-169.
9. Wallner KE, Galicich JH, Malkin MG, Arbit E, Krol G, Rosenblum MK. Inability of computed tomography appearance of recurrent malignant astrocytoma astrocytoma to predict survival following reoperation. J Clin Oncol 1989; 7:1492-1496.
10. Burger PC, Kleihues P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989; 63:2014-2023.
11. Glantz MJ, Hoffman JM, Coleman RE, et al. Identification of early recurrence of primary central nervous system tumors by [18F) fluorodeoxyglucose positron emission tomography. Ann Neurol 1991; 29:347-355.
12. Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of 201-T1 SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994; 163:1459-1465.
13. Kosuda S, Fujii H, Aoki S, et al. Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 1994; 30:1201-1206.
14. Carvalho PA, Schwartz RB, Alexander E III, et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computed tomography. J Neurosurg 1992; 77:565-570.
15. Schwartz RB, Holman BL, Garada BM, et al. Dual isotope SPECT predicts histology and survival in patients after high-dose radiotherapy for malignant astrocytoma. Neurosurg Focus 1996; 1.
16. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133:275-288.